Tage Honore
CIK: 0001967946
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VNDA
Vanda Pharmaceuticals Inc.
Director
Discretionary Trading P&L
Holdings
About Honore Tage
Honore Tage (SEC CIK 0001967946) files insider reports with the SEC as Director of Vanda Pharmaceuticals Inc. (VNDA).
Signal8 holds 3 ownership filings by Honore Tage, all Form 4s, filed between Jun 9, 2025 and Jun 8, 2026. Those filings report 3 transactions, from Jun 5, 2025 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Honore Tage's filings is in WASHINGTON, DC.
Recent filings by Honore Tage
Other insiders filing for Vanda Pharmaceuticals Inc. (VNDA)
- McGuire Daniel Patrick, SVP, GC and Secretary
- Chrousos Phaedra, Director
- Duncan Charles Cliff, Director
- DUGAN RICHARD W, Director
- Ward Anne Sempowski, Director
- Mitchell Stephen Ray, Director